March 9, 2010 – As an alternative to the technetium (Tc-99M) isotope used in many nuclear imaging studies, UltraSPECT is ...
March 8, 2010 – A new U.S. source for the positron emission tomography (PET) agent F18 sodium fluoride is now offered ...
February 17, 2010 — An agreement has been reached to further augment and diversify a manufacturer's supply of molybdenum ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
January 26, 2010 – The U.S. Department of Energy’s National Nuclear Security Administration (NNSA) selected GE Hitachi ...
January 25, 2010 - Heart failure is a serious medical condition, in which the heart muscle progressively loses its ...
December 18, 2009 - The U.S. radiopharmacy network currently owned by Covidien is being sold to Triad Isotopes in a deal ...
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
December 15, 2009 - The New FDA guidelines on current good manufacturing practices (cGMPs) for the production of ...
December 9, 2009 - An expert panel reviewing Canadian medical isotope productions selected electron beam technology as a ...
November 18, 2009 – The Centers for Medicaid and Medicare Services (CMS) recently announced it will increase the ...
November 13, 2009 – A new imaging agent for measuring and monitoring cathepsin B activity associated with disease ...
November 6, 2009 - As the American Medical Isotopes Production Act of 2009 now heads to the U.S. Senate for approval ...
November 4, 2009 - The Centers for Medicare and Medicaid Services (CMS) released the review copy of the 2010 Hospital ...
November 2, 2009 - PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions, announced it is a ...
October 28, 2009 - The imaging industry, especially the new molecular technologies, will drive personalized medicine, in ...
October 20, 2009 - 2-18F-fluoropropionic acid (18F-FPA) as a PET tracer for imaging prostate cancer has potential for ...
October 8, 2009 - Bayer Schering Pharma AG, Germany, will provide its development candidate florbetaben, a PET (positron ...
September 23, 2009 - The results of the Phase 0 (exploratory), or “first-in-human,” study indicated that the bio ...
September 21, 2009 - GE Healthcare hosts two consortium workshops on imaging technologies and molecular imaging agents ...
September 21, 2009 – IBA (Ion Beam Applications S.A.), a provider of PET radiopharmaceuticals, and Aposense Ltd., a ...
“Our profession faces one of the most significant crises in its history,” said Michael Graham, M.D., president of the ...